Stay updated on LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.

Latest updates to the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, reflecting a new page version without changing substantive content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, signaling a minor update to the ClinicalTrials.gov record. This change reflects a backend or layout update without altering the study data or eligibility criteria.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page's revision was updated from v3.6.0 to v3.6.2, representing a minor update to the page rendering.SummaryDifference0.1%

- Check47 days agoChange DetectedFooter and site-wide navigation/policy elements were removed from the page, reducing the amount of footer information visible on the study record.SummaryDifference22%

- Check54 days agoChange DetectedRecruitment status now indicates no active enrollment. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the treatment heading formatting was adjusted (Intervention/Treatment).SummaryDifference0.5%

- Check61 days agoChange DetectedRevision tag on the page updated from v3.5.4 to v3.5.5. This reflects a minor update to the page or site template.SummaryDifference0.1%

Stay in the know with updates to LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.